Relationship between Sleep Quality and Anxiety-Depressive Disorders in Moroccan Women with Breast Cancer: A Cross-Sectional Study.

Anxiety Associated factors Breast cancer Depression Sleep quality

Journal

Iranian journal of public health
ISSN: 2251-6093
Titre abrégé: Iran J Public Health
Pays: Iran
ID NLM: 7505531

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 20 04 2022
accepted: 14 07 2022
medline: 18 8 2023
pubmed: 18 8 2023
entrez: 18 8 2023
Statut: ppublish

Résumé

Breast cancer is the most common female cancer in the world. Sleep disruption is one of the major problems of breast cancer patients. This study aimed to evaluate the quality of sleep in a group of Moroccan women with breast cancer and analyze the association between sleep quality, depression, and anxiety. This cross-sectional study was carried out among 337 Moroccan women treated for breast cancer at the Mohammed VI Cancer Treatment Center in Casablanca in 2019. A questionnaire was designed for this purpose based on two scales: Pittsburgh Sleep Quality Index (PSQI) and Hospital Anxiety Depression Scale (HADS). 71.5% of the participants had significant sleep disturbances; the subjective quality of patients' sleep was considered to be quite poor (20.8%) and 43.9% of participants need more than 60 minutes to fall asleep. The average sleep duration was 6.16 h/night and 84.3% of patients had not taken sleep medicines in the last month. The most common reasons for sleep disturbances were getting up to use the bathroom (67.4%) and waking up in the middle of the night or early morning (54%). Anxiety and depression were positively correlated with PSQI scores. The present study highlights how much breast cancer patients are vulnerable to psychological disorders and then incites the decision makers in oncology departments to implement rigorous psychological health care strategies in order to ameliorate mental health and sleep quality of breast cancer patients.

Sections du résumé

Background UNASSIGNED
Breast cancer is the most common female cancer in the world. Sleep disruption is one of the major problems of breast cancer patients. This study aimed to evaluate the quality of sleep in a group of Moroccan women with breast cancer and analyze the association between sleep quality, depression, and anxiety.
Methods UNASSIGNED
This cross-sectional study was carried out among 337 Moroccan women treated for breast cancer at the Mohammed VI Cancer Treatment Center in Casablanca in 2019. A questionnaire was designed for this purpose based on two scales: Pittsburgh Sleep Quality Index (PSQI) and Hospital Anxiety Depression Scale (HADS).
Results UNASSIGNED
71.5% of the participants had significant sleep disturbances; the subjective quality of patients' sleep was considered to be quite poor (20.8%) and 43.9% of participants need more than 60 minutes to fall asleep. The average sleep duration was 6.16 h/night and 84.3% of patients had not taken sleep medicines in the last month. The most common reasons for sleep disturbances were getting up to use the bathroom (67.4%) and waking up in the middle of the night or early morning (54%). Anxiety and depression were positively correlated with PSQI scores.
Conclusion UNASSIGNED
The present study highlights how much breast cancer patients are vulnerable to psychological disorders and then incites the decision makers in oncology departments to implement rigorous psychological health care strategies in order to ameliorate mental health and sleep quality of breast cancer patients.

Identifiants

pubmed: 37593511
doi: 10.18502/ijph.v52i7.13247
pii: IJPH-52-1457
pmc: PMC10430391
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1457-1465

Informations de copyright

Copyright © 2023 El Kherchi et al. Published by Tehran University of Medical Sciences.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that there is no conflict of interests.

Références

Soc Sci Med. 2002 May;54(9):1309-21
pubmed: 12058848
Appl Nurs Res. 2017 Apr;34:7-11
pubmed: 28342628
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
Palliat Med. 2009 Jan;23(1):46-53
pubmed: 18838488
Acta Psychiatr Scand. 1991 Oct;84(4):323-6
pubmed: 1746281
Breast Cancer. 2014 Mar;21(2):208-13
pubmed: 22661104
J Psychosom Res. 2007 May;62(5):527-33
pubmed: 17467407
J Clin Nurs. 2005 Jan;14(1):107-13
pubmed: 15656855
Sch Inq Nurs Pract. 2000 Winter;14(4):275-90; discussion 291-8
pubmed: 11372188
Asian Pac J Cancer Prev. 2018 Jun 25;19(6):1661-1669
pubmed: 29938451
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Gac Sanit. 2017 Jan - Feb;31(1):18-22
pubmed: 27474487
West J Nurs Res. 2010 Mar;32(2):250-68
pubmed: 19915205
Curr Probl Cancer. 2020 Feb;44(1):100504
pubmed: 31548046
Nurs Open. 2021 May;8(3):1030-1037
pubmed: 34482659
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
J Pain Symptom Manage. 2002 Nov;24(5):471-80
pubmed: 12547047

Auteurs

Ouassil El Kherchi (O)

Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Epidemiology and Biomedical Unit, 26000, Settat, Morocco.

Amina Aquil (A)

Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Epidemiology and Biomedical Unit, 26000, Settat, Morocco.

Noureddine Elkhoudri (N)

Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Epidemiology and Biomedical Unit, 26000, Settat, Morocco.

Maroua Guerroumi (M)

Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Epidemiology and Biomedical Unit, 26000, Settat, Morocco.

Naoual El Azmaoui (N)

Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Epidemiology and Biomedical Unit, 26000, Settat, Morocco.

Mustapha Mouallif (M)

Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Epidemiology and Biomedical Unit, 26000, Settat, Morocco.

Salma Aitbouighoulidine (S)

Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Epidemiology and Biomedical Unit, 26000, Settat, Morocco.

Aziz Chokri (A)

Hassan First University of Settat, Institut des Sciences du Sport, 26000, Settat, Morocco.

Abdellatif Benider (A)

Ibn Rochd University Hospital Center, Mohammed VI Center for the Treatment of Cancers, Casablanca, Morocco.

Abdeljalil Elgot (A)

Hassan First University of Settat, Higher Institute of Health Sciences, Laboratory of Sciences and Health Technologies, Epidemiology and Biomedical Unit, 26000, Settat, Morocco.

Classifications MeSH